Merck & Co. is chasing the finish line with its eye on one prize: a world without cancer. | In “From Our Pipeline to the ...
Would you know the difference between a normal cold and one that has turned into something more serious? | Would you know the ...
Amid surging sales of Rezdiffra, Madrigal Pharmaceuticals is facing a whistleblower lawsuit alleging that senior leadership ...
Bristol Myers Squibb Canada is partnering with TANK Worldwide and Ogilvy Health on a new “What Summer Leaves Behind” skin ...
Knudsen’s departure will mark the end of a 27-year run at Novo, with Doustdar telling analysts Wednesday that the outgoing ...
Samsung Biologics' labor union has another strike in the works after action planned for last month was held up by an ...
In a major reshaping of the pharmaceutical contract manufacturing landscape, Lonza has struck a deal to acquire the CDMO ...
Biopharma industry veteran Jackie Elbonne, Ph.D., is retiring at the end of the year, leaving Amgen’s top quality spot to her ...
Karyopharm Therapeutics filed for Chapter 11 bankruptcy as part of a plan to merge with Irish hematology biotech, Ayrmid. Massachusetts-based Karyopharm’s financial woes came to a head in August, when ...
To Bill Sibold, “it’s hard to find a more attractive growth opportunity in biotech” than metabolic dysfunction-associated steatohepatitis (MASH). | To Madrigal CEO Bill Sibold, “it’s hard to find a ...
Bayer’s pharmaceutical business may finally be entering a long-awaited growth cycle, but CEO Bill Anderson still can’t quite ...
In a pair of recently disclosed reports, the FDA outlined manufacturing concerns at separate facilities run by China's Hansoh ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results